Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kymera Therapeutics (KYMR) Non Operating Income: 2019-2024

Historic Non Operating Income for Kymera Therapeutics (KYMR) over the last 6 years, with Dec 2024 value amounting to $37.8 million.

  • Kymera Therapeutics' Non Operating Income rose 7.36% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.1 million, marking a year-over-year increase of 13.51%. This contributed to the annual value of $37.8 million for FY2024, which is 103.45% up from last year.
  • Kymera Therapeutics' Non Operating Income amounted to $37.8 million in FY2024, which was up 103.45% from $18.6 million recorded in FY2023.
  • In the past 5 years, Kymera Therapeutics' Non Operating Income ranged from a high of $37.8 million in FY2024 and a low of $313,000 during FY2021.
  • In the last 3 years, Kymera Therapeutics' Non Operating Income had a median value of $18.6 million in 2023 and averaged $20.9 million.
  • In the last 5 years, Kymera Therapeutics' Non Operating Income plummeted by 55.98% in 2021 and then soared by 1,960.06% in 2022.
  • Yearly analysis of 5 years shows Kymera Therapeutics' Non Operating Income stood at $711,000 in 2020, then slumped by 55.98% to $313,000 in 2021, then spiked by 1,960.06% to $6.4 million in 2022, then skyrocketed by 187.97% to $18.6 million in 2023, then spiked by 103.45% to $37.8 million in 2024.